EP0781154A2 - Appareil de phototherapie - Google Patents

Appareil de phototherapie

Info

Publication number
EP0781154A2
EP0781154A2 EP95933733A EP95933733A EP0781154A2 EP 0781154 A2 EP0781154 A2 EP 0781154A2 EP 95933733 A EP95933733 A EP 95933733A EP 95933733 A EP95933733 A EP 95933733A EP 0781154 A2 EP0781154 A2 EP 0781154A2
Authority
EP
European Patent Office
Prior art keywords
radiation
housing
fiber
tip
light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP95933733A
Other languages
German (de)
English (en)
Inventor
Edward L. Sinofsky
Lincoln S. Baxter
Norman Farr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardiofocus Inc
Original Assignee
Rare Earth Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/471,744 external-priority patent/US5637877A/en
Priority claimed from US08/467,414 external-priority patent/US5632767A/en
Priority claimed from US08/468,568 external-priority patent/US5643253A/en
Application filed by Rare Earth Medical Inc filed Critical Rare Earth Medical Inc
Priority to EP05000735A priority Critical patent/EP1527798A3/fr
Publication of EP0781154A2 publication Critical patent/EP0781154A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B2018/2255—Optical elements at the distal end of probe tips
    • A61B2018/2261—Optical elements at the distal end of probe tips with scattering, diffusion or dispersion of light

Definitions

  • the technical field of this invention is phototherapy and, in particular, methods and devices which employ optical fibers or other flexible light waveguides to deliver radiation to a targeted site.
  • Fiber optic phototherapy is a increasing popular modality for the diagnosis and or treatment of a wide variety of diseases.
  • mfrared laser radiation will often be delivered to a surgical site via a hand-held instrument incorporating an optically transmissive fiber in order to coagulate blood or cauterize tissue.
  • Similar fiber optic delivery systems have been proposed for endoscopic or catheter-based instruments to deliver therapeutic radiation to a body lumen or cavity.
  • U.S. Patent No. 4, 336,809 (Clark) and U.S. Reissue Patent No. RE 34,544 (Spears) disclose that hematoporphyrin dyes and the like selectively accumulate in tumorous tissue and such accumulations can be detected by a characteristic fluorescence under irradiation with blue light.
  • cancerous tissue that has taken up the dye can be preferentially destroyed by radiation (typically high intensity red light) that is absorbed by the dye molecules during phototherapy.
  • U.S. Patent 4,878,492 discloses the used of infrared radiation to heat blood vessel walls during balloon angioplasty in order to fuse the endothelial lining of the blood vessel and seal the surface.
  • Another application of fiber-delivered radiation is disclosed in U.S. Patent 5,053,033 (Clarke) which teaches that restenosis following angioplasty can be inhibited by application of UV radiation to the angioplasty site to kill smooth muscle cells which would otherwise proliferate in response to angioplasty- induced injuries to blood vessel walls.
  • an optical fiber emits light from only its end face.
  • the emitted light tends to be focused or at best divergent in a conical pattern and, therefore, exposes only a small region directly in front of the fiber's distal end.
  • the small exposure area limits the power available for phototherapy since overheating of the target tissue must often be avoided.
  • sideways-emitting fibers have been proposed to permit greater flexibility in phototherapy, this approach still does not allow uniform irradiation of large volumes of tissue and can also be ill-suited for applications where circumferential uniformity is desired. Because sideways-emitting fibers expose limited regions, they do little to alleviate the problem of "hot spots" which limit the intensity of radiation which can be delivered via the fiber to the treatment site. Others have proposed diffusive tips for optical fibers to enlarge the region which can be irradiated and or reduce the potential for overexposure.
  • diffusive tips have not been satisfactory for many therapeutic purposes because of their complexity of manufacture and/or because the radiation may not be scattered uniformly enough to alleviate the problem of "hot spots.”
  • Prior art diffusive tip structures have not be capable of delivering high power radiation, e.g., on the order of ten watts or more, to facilitate photocoagulation therapy or the like.
  • diffusive fiber tip assemblies which can provide circumferential (or large angle) exposure regions in radial directions (e.g., sideways) relative to the fiber axis without hot spots would satisfy a long-felt need in the art.
  • diffusive assemblies which illuminate or irradiate an azimuthal angle of less than 360° would meet a particularly important need in the field of minimally-invasive, phototherapeutic surgery.
  • diffusive assemblies that provide graded or broadly-cast exposure patterns, or otherwise predefined patterns of light distribution would also meet particular needs.
  • diffusive fiber tip assemblies which can extend the longitudinal extent of irradiation and provide greater flexibility during use would also satisfy a need in phototherapy.
  • phototherapeutic instruments can be employed to treat electrical arrhythmia of the heart.
  • a catheter having a fiber optic component is fed via a major artery into a patient's heart. Once inside the heart, a catheter senses electrical impulses with electrical contacts on its outer sheath or other catheter elements in order to locate the source of arrhythmia . Once located, the phototherapeutic component is activated to "ablate" a portion of the inner heart wall. By coagulating the tissue in the vicinity of the a ⁇ hythmia source, the likelihood that the patent's heart will continue to experience arrhythmia is thus reduced.
  • laser radiation can be used in conjunction with a similar catheter instrument inside a patient's heart to increase blood flow to oxygen starved regions of the heart muscle.
  • the laser radiation is used to form small holes into the hear muscle so that the oxygen-depleted tissue is bathed with blood from the ventricular cavity.
  • there is the potential for damage to the patient's internal organs, especially the heart if the light-emitting fiber is inserted too far into the patient's tissue.
  • perforation of the heart wall can have very dangerous effects.
  • endoscopes are sterilized using a chemical bath.
  • the internal lumens of the instrument will either be soaked in a sterilizing liquid or flushed with the sterilizing liquid.
  • conventional techniques can sometimes be less than totally effective.
  • the sterilizing liquid may not penetrate the entire lumen or may not be sufficiently strong to achieve the desired antimicrobial effect.
  • the endoscope lumen may have accumulated cellular debris that cannot be simply flushed out and such debris may harbor microbes that are not destroyed in the cleaning process. Accordingly, there exists a need for better methods and devices for sterilizing the inner lumens of endoscopic instruments. Methods and devices which could ensure more effective anti-microbial action and/or permit more rapid sterilization of instrument lumens, would satisfy a long-felt need in the art.
  • Methods and apparatus are disclosed for diffusing radiation from a optical fiber to provide a larger exposure area for phototherapy.
  • the methods and apparatus are particularly useful as part of fiber optic-based medical laser systems.
  • the present invention can further provide substantially uniform or otherwise predefined patterns of energy distribution to a major portion of the exposure area.
  • the invention is especially useful in constructing and implementing circumferential, broadly-cast, graded and or sideways-emitting diffusive tip assemblies for optical fibers to direct laser radiation in one or more radially outward patterns relative to the fiber's axis.
  • optical fiber is intended to encompass optically transmissive waveguides of various shapes and sizes.
  • an optical transmissive fiber tip structure having a radiation-scattering particles and a reflective end.
  • the radiation is scattered.
  • the remaining radiation or at least a major portion of this returning radiation again encounters the scatterers which provide further radial diffusion of the radiation.
  • a diffusive tip assembly for diffusing radiation from an optical fiber.
  • the tip assembly includes a light transmissive, tubular housing alignable with, and adapted to receive, the distal end of the fiber and serve as a waveguide for light propagating through the fiber.
  • the assembly further includes a reflective end cap and a light scattering medium disposed therein such that light propagating through said fiber enters the scattering medium and a portion of the light escapes outward through the housing, and another portion passes through the scattering medium and is reflected by the end cap for retransmission through said scattering medium.
  • the reflective surfaces of the apparatus can also be modified to effect non-cylindrical or non-spherical exposure patterns.
  • Reflective structures are disclosed which control the azimuthal extent of the light emitted from the tip. These techniques and structures permit, for example, 270 degrees, 180 degrees or even smaller angles of azimuthal exposure.
  • the term "large angle exposure” is used herein to describe partially cylindrical (or partially spherical) exposure patterns having a azimuthal angle of more than about 90 degrees.
  • the amount of incorporated scatterers and or the length of the diffusive tip can be controlled such the diffusion of the radiation beam during the initial and reflected paths are complementary.
  • the cumulative energy density or fluence along at least a portion of the length of fiber tip can be rendered uniform. The invention thus provides a mechanism for uniform cylindrical irradiation of biological structures and the like.
  • the amount of incorporated scatterers can be varied to create a graded or otherwise varied pattern of exposure. For example, more scatterers can be incorporated into a distal portion of the diffuser assembly to create a progressively increasing exposure pattern.
  • a transparent teflon rod can transmit to a distal mirror to create an increasing intensity distal to the fiber.
  • bundling techniques and configurations are disclosed for extending the axial extent of diffusive irradiation and/or for permitting selective activation of fibers or fiber subsets to effect site-specific phototherapy of regions or sectors of a patient's tissue in the vicinity of the optical fiber tip.
  • Such bundled systems can also be used to deliver two or more different wavelengths of radiation to the treatment site and thereby provide synergistic effects from multiple wavelengths of therapy, or permit diagnostic and therapeutic radiation of different wavelengths to be delivered in a single procedure.
  • novel materials and structures are disclosed for diffusive tip assemblies to alleviate or reduce the potential for contact-adhesion between the tip and nearby tissue segments.
  • This aspect of the invention is particularly useful in connection with endoscopic and/or catheter-based phototherapy to ensure that the diffusive tip does not bond accidentally to the body lumen or blood vessel wall during procedures.
  • fluoropolymer materials such as Teflon® materials and the like, are disclosed as preferred materials for the tip enclosure and/or the outer cladding or coating to inhibit contact-adhesion between the tip assembly and biological tissue during procedures.
  • the Teflon® material is a Teflon® FEP material (a polyperfluoroethylene- propylene copolymer).
  • Teflon® materials such as Teflon® PFA (a polytetrafluoroethylene polymer with perfluoroalkoxy side chains) and Teflon® PTFE (polytetrafluoroethylene) also can be useful in certain applications.
  • Teflon® PFA a polytetrafluoroethylene polymer with perfluoroalkoxy side chains
  • Teflon® PTFE polytetrafluoroethylene
  • novel scatterer structures are disclosed which permit the diffusion of ultraviolet (UV) and infrared (IR) radiation with higher efficiency than prior art structures.
  • Liquid-filled scattering assemblies and, in particular, structures employing deuterium oxide and other heavy water solutions are disclosed which transmit IR light with low losses and minimal tip heating. Distilled water suspensions of scatterers are disclosed for UV light delivery.
  • novel treatment protocols are disclosed for rmnimally invasive phototherapeutic surgery.
  • protocols for the treatment of prostate cancer and similar diseases are disclosed in which a diffusive tip assembly is placed in the vicinity of the cancerous organ or body structure and diffuse light is used to heat and selectively destroy cancerous or dysplastic tissue.
  • the present invention can be use for the closure of body ducts and/or the reconstruction of competent junctures between ducts or valves that have been malformed or damaged.
  • photoactivation of pharmacological agents, implanted structures, or suture materials can all be advantageously effected with the diffusive assemblies of the present invention.
  • the phototherapeutic devices disclosed herein can be used to sterilize medical instruments.
  • a plurality of optically-transmissive fiber tip assemblies are disclosed to act as diffusers.
  • the two or more fiber tip assemblies are deployed as loops which create a broadly cast and relatively uniform illumination pattern.
  • looping or “folding” the fibers, a plurality of fibers can be deployed in conjunction with one another to create geometric exposure patterns with increased energy density while still avoiding "hot spots.”
  • loop diffusers can be incorporated into an endoscopic instrument or catheter.
  • the diffusive elements can be initially deployed in a retracted position (largely within the body of the instrument) and then redeployed with the help of a control wire or the like in an expanded configuration.
  • the two or more loops in the expanded configuration can create a "globe-like" diffuser assembly, or, if further extended, the loops can form a "heart shaped configuration.
  • the invention thus permits a relatively small instrument to be enlarged to project a wide exposure area.
  • the individual loops each include a light transmissive, tubular housing aligned with, or adapted to receive, the distal end of a fiber and serve as a wave guide for light propagating through the fiber.
  • the tubular housing can be a hollow tube filled with a scattering medium and an optical fiber is joined to each end. Light propagating through the fibers will enter opposite ends of the housing and be scattered before reaching the other end
  • the assembly can be attached to a single fiber and further includes an end cap and a light scattering medium disposed within the housing such that light propagating through the fiber enters the scattering medium and a portion of the light escapes outward through the housing.
  • the end cap is a simple stopper and substantially all of the light eventually is scattered before it reaches the stopper.
  • the end cap can include a reflective surface such that as the light propagates through the fiber some of it is initially scattered by the scattering medium and exits radially, while another portion passes through the scattering medium and is reflected by the end cap for transmission through the scattering medium again.
  • the amount of incorporated scatterers and/or the length of the diffusive loop can be controlled such that the diffusion of the radiation beam during the initial and the reflected paths are complementary. By proper choice of parameters, the cumulative energy density or fluence along at least a portion of the length of the fiber tip can be rendered uniform.
  • disposable sheaths are disclosed for use in conjunction with the diffuser assemblies.
  • the outer sheath surrounds the entire optical transmission apparatus and ensures that the radiation-generating components do not come into direct contact with the patient's body structures. This permits reuse of the instrument. Only the sheath surrounding the apparatus needs to be disposed after each use. Phototherapeutic instruments are also disclosed having integral stopper devices which limit the penetration of an optical fiber tip.
  • a fluted outer sheath is disposed about an internal optical fiber. The fluted sheath is configured to fold into an expanded form during penetration into a patient's tissue. As the sheath is forced back and expands, the optically-transmissive assembly presents a much larger cross-sectional area which prevents penetration of the instrument beyond a pre-determined desirable distance.
  • the invention is particularly useful in limiting an optically-transmissive fiber's penetration and, thereby, reduce the possibility of perforation of a body lumen or organ.
  • the invention is particularly useful in placing a "ablative" laser radiation device into the ventricle of the heart when performing arrhythmia-correcting laser ablative procedures or when revascularizing the heart percutaneously. In these types of procedures, the surgeon seeks to partially penetrate the heart muscle while not fully perforating the heart wall.
  • the stopper devices of the present invention limit penetration and stabilized the optically-transmissive tip during phototherapy.
  • the structures disclosed herein represent a substantial step forward in the delivery of therapeutic radiation to remote treatment sites.
  • the diffusive assembly designs of the present invention permit the delivery of radiation at power levels on the order of tens of Watts or more.
  • diffusive tip assemblies have been successfully constructed to deliver over 100 Watts of power in a diffuse pattern to a treatment site, allowing the clinician to perform therapy rapidly and uniformly to a large volume of tissue.
  • Methods and devices are further disclosed for sterilization of endoscopic instrument lumens. Diffuse ultraviolet radiation is employed to sterilize the inner surfaces of the instrument lumen.
  • the ultraviolet radiation can be delivered via one or more optical fibers having a light-diffusing assembly coupled thereto.
  • the instrument operates by delivering cytotoxic radiation to the inner lumen surface to sterilize any biological agents which may be present within the instrument lumen.
  • a lumen sterilizing apparatus having a light transmitting fiber which is capable of transmitting ultraviolet radiation.
  • the apparatus further includes a diffuser means, coupled to the fiber for diffusing ultraviolet radiation from the fiber.
  • the fiber and diffuser are sufficiently small so as to fit within an endoscope lumen.
  • the apparatus further includes an irradiation means for generating ultraviolet radiation and for coupling the radiation to the fiber.
  • the sterilizing ultraviolet radiation preferably ranges from about 400 to about 200 nanometers in wavelength and, more preferably, from about 300 to 220 nanometers, and most preferably, from about 280 to 240 nanometers.
  • Such radiation can be obtained from a laser source, such as an Argon ion laser or an excimer laser (such as a Xenon Chloride excimer laser).
  • a solid state laser can be used in conjunction with frequency modifying element.
  • an infrared radiation source can be used in conjunction with two frequency-doubling crystals, which cooperate to yield a frequency-quadrupled radiation beam in the ultraviolet spectrum.
  • a simple ultraviolet flash lamp can be employed as the light source and coupled to the optical fiber.
  • the optical fiber can be any conventional optic transmission element including, for example, fused silica.
  • the term "optical fiber" is intended to encompass optically transmissive wave guides of various shapes and sizes.
  • a diffusing tip can be employed in conjunction with the optical fiber to deliver diffuse cytotoxic radiation to the inner lumen.
  • the diffusive fiber tip structure can be formed by radiation-scattering particles carried in a suitable transmission medium
  • the diffusing tip can be constructed from a tubular element filled with any suitable medium that diffuses light without the need for paniculate scatterers.
  • a longer tube filled with water or acetic acid can also serve as the scattering medium.
  • the apparatus can be used to sterilize a substantial portion, or the entire length, of the lumen all at once.
  • novel materials and structures are disclosed for diffusive tip assemblies which further alleviate or reduce the potential for contact-adhesion between the tip and the nearby lumen wall.
  • This aspect of the invention is particularly useful to ensure that the diffusive tip does not accidentally bond to the instrument lumen or debris within the lumen.
  • fluoropolymer materials such as Teflon® materials and the like are disclosed as preferred materials for the tip enclosure because of their low contact-adhesion characteristics, deep ultraviolet trans issivity and low refractive index.
  • disposable sheaths are disclosed for use in conjunction with the ultraviolet sterilizing fiber and diffuser assembly.
  • the outer sheath surrounds the entire optical transmission apparatus and ensures that the radiation-generating components do not come into direct contact with the instrument lumen or the debris which may be present in such lumen. This permits reuse not only of the endoscope repeatedly by a clinician, but also reuse of the sterilizing instrument. Only the sheath surrounding the sterilization apparatus need to be disposed after each use. Alternatively, a disposable sheath/diffuser can be used in conjunction with a reusable fiber. Thus, a disposable sheath filled with a light scattering medium can be fitted to a reusable fiber and then used to perform instrument sterilization. When the procedure is completed, the sheath and the scattering medium inside can then be discarded.
  • methods are disclosed for perfo ⁇ ning instrument sterilization. These methods typically involve the placement of an ultraviolet radiation- diffusing assembly within the endoscopic instrument lumen and then the pulling of the sterilization apparatus through the lumen such that the entire inner surface is bathed with cytotoxic radiation.
  • the method can further include the use of a disposable outer sheath which surrounds the sterilization apparatus while it is being pulled through the lumen and then is discarded after the sterilization procedure is completed.
  • endoscopic instrument and "endoscope” are used herein to describe a general class of instrument useful in viewing internal body structures or rjerforming operations within a patient's body, including cystoscopes, tracheoscopes, culpascopes, proctoscopes, laprascopes, catheters, arthroscopes, other endoscopes and the like.
  • cystoscopes tracheoscopes
  • culpascopes proctoscopes
  • laprascopes catheters
  • arthroscopes other endoscopes and the like.
  • FIG. 1 is a cross-sectional illustration of a phototherapeutic apparatus incorporating an optical fiber and a diffusive tip assembly in accordance with the present invention
  • FIG. 2 is another cross-sectional illustration of a phototherapeutic apparatus in accordance with the present invention incorporating a plurality of optical fibers and a diffusive tip assembly;
  • FIG. 2A is a cross-sectional view of the optical fiber diffusive tip assembly of
  • FIG. 2 taken along the line A-A of FIG. 2;
  • FIG. 3 is another cross-sectional illustration of a phototherapeutic apparatus in accordance with the present invention incorporating a plurality of optical fibers and a diffusive tip assembly in which the fibers have different terminal points within the assembly;
  • FIG. 3A is perspective view of the end portions of the optical fibers of FIG. 3;
  • FIG. 4 is another cross-sectional illustration of a phototherapeutic apparatus in accordance with the present invention incorporating a multilayer laminated scatterer tube element
  • FIG. 5 is another cross-sectional illustration of a phototherapeutic apparatus in accordance with the present invention incorporating a longitudinal reflector to provide azimuthal selectivity in a diffusive tip assembly
  • FIG. 5A is a cross-sectional view of the optical fiber diffusive tip assembly of FIG. 5 taken along the line A-A of FIG. 5;
  • FIG. 6 A is a cross-sectional illustration of an alternative reflector design useful in diffusive tip assemblies according to the invention;
  • FIG. 6B is a cross-sectional illustration of another alternative reflector design useful in diffusive tip assemblies according to the invention.
  • FIGS. 7 A, 7B, and 7C are graphs illustrating the relationship between relative intensity and axial distance from the fiber end face for various scatterer loading concentrations
  • FIG. 8 is graph of intensity versus axial position for various mirror placements in diffusive tip assemblies according to the invention.
  • FIG. 9 is graph of intensity versus axial position for an actual diffusive tip assembly according to the invention.
  • FIG. 10 is a graph of azimuthal intensity distribution of two diffusive tip assemblies according to the invention, one providing a cylindrical exposure pattern and the other providing a semi-cylindrical pattern;
  • FIG. 11 is graph of the transmission spectrum of Teflon® FEP illustrating the relationship between transmissivity and wavelength
  • FIG. 12 is a cross-sectional illustration of another phototherapeutic apparatus according to the invention having two chambers filled with different scattering media to effect an increasing diffusion pattern;
  • FIG. 13 is a is a schematic perspective view of a loop diffuser in accordance with the present invention.
  • FIG. 14A is a side view of a loop diffuser in which the diffusive elements are fully retracted
  • FIG. 14B is a side view similar to that of FIG. 14A in which the loop diffuser elements are partially deployed;
  • FIG. 14C is a further side view of the instrument in which the loop diffuser elements are fully deployed;
  • FIG. 14D is a further side view of the instrument in which the loop diffuser elements are fully deployed with the control wire partially retracted to effect a "heart-shaped" diffuser;
  • FIG. 15A is a cross-sectional view of an optical fiber diffusive tip assembly for use in the apparatus of FIG. 13.
  • FIG. 15B is a graph of intensity vs. axial distance for the loop diffuser of FIG. ISA;
  • FIG. 16 is a cross-sectional view of another optical fiber diffusive tip assembly for use in the apparatus of FIG. 13;
  • FIG. 17 is a schematic view of the use of present invention as part of an endoscopic system
  • FIG. 18 is a further cross-sectional view of an optical fiber and diffusive tip assembly in accordance with the present invention, further employing a disposable outer sheath;
  • Fig. 19 a schematic, perspective field of the distal end of a phototherapeutic apparatus and integral stopper device in accordance with the present invention;
  • Fig. 20 is a cross-sectional illustration of the phototherapeutic apparatus of Fig. 19;
  • Fig. 21 is a schematic view of the present invention as part of a catheter or endoscopic system
  • Fig. 22 A illustrates the phototherapeutic apparatus of the present invention deployed in an initial position prior to contacting the surface of a body organ or lumen
  • Fig 22B is a further illustration of the apparatus of Fig 22 A after initial penetration of body tissues
  • Fig. 22C is a further schematic illustration of the penetration of the phototherapeutic apparatus of Fig 22 A in which the stopper mechanism is partially deployed;
  • Fig.22D is a further illustration of the apparatus of Fig.22 A in which the stopper device is fully deployed.
  • FIG. 23 is a schematic view of an phototherapeutic apparatus for sterilization of medical instruments according to the invention
  • FIG. 24 is a cross-sectional view of an optical fiber diffusive tip assembly for use in the sterilization apparatus of FIG.23;
  • FIG.25 is a cross-sectional view of an optical fiber and diffusive tip assembly in accordance with the present invention, further employing a disposable outer sheath.
  • an optical fiber diffusive tip assembly 10 including an optical fiber 12 having a light-transmissive core 14, a cladding 16, and an outer buffer coating 18.
  • the end face of fiber core 14 is inserted into a housing 20 which contains scattering medium 22 with individual scatterer particles 24.
  • the medium 22 has a greater refractive index then the housing 20.
  • an end plug 26 is disposed with a mirror reflector 28
  • Light propagating through optical fiber core 14 is transmitted into the scatterer medium 22 and scattered in a cylindrical pattern along the length of the assembly 10. Each time the light encounters a scatterer particles, it is deflected and, at some point, the net deflection exceeds the critical angle for internal reflection at the interface between the housing 20 and medium 22. When this happens, the light will exit. Light which does not exit during this initial pass through the tip is reflected by the mirror 28 and returned through the tip assembly. During the second pass, the remaining radiation (or at least a major portion of this returning radiation) again encounters the scatterers 22 which provide further circumferential diffusion of the light.
  • FIGS. 2 and 2A another diffusive tip assembly 40 is shown having essentially identical elements to those shown in FIG. 1, except for the disposition of a bundle of optical fibers 12A-12E. The individual cores of the fibers are exposed and transmit light into the scatterer medium 22.
  • FIG. 2 A is a cross-sectional view of the device of FIG. 2 showing the placement of the bundle of optical fibers 12A-12E and the surrounding tube 20, scatterer medium 22 and reflector 28.
  • FIGS.3 and 3 A another diffusive tip assembly 40 A is shown again having essentially identical elements to those shown in FIG. 1, except for the disposition of a bundle of optical fibers 12A-12E.
  • the individual cores of the fibers are exposed and transmit light into the scatterer medium 22, but the individual fibers terminate at different locations within housing 20, thereby permitting extended axial diffusion.
  • FIG. 3 A is a perspective view of the fiber bundle of FIG. 3 showing the placement of the bundle of optical fibers 12A-12E within the housing.
  • FIG. 4 an alternative diffuser tip assembly 50 is shown in which a laminate of multiple layers is used for the scatterer tube 20.
  • innermost layer 20A encases the scatterer medium 22.
  • Surrounding this innermost layer 20A is an intermediate layer 20B.
  • a third optional layer 20C is then formed about the first two layers 20A, 20B.
  • Such a configuration permits the use of different polymeric tubing materials and/or allows the introduction of pigmented or etched structures as part of tubing 20.
  • FIG. 5 another embodiment of a diffusing tip assembly 60 is shown incorporating a longitudinal reflector strip 62.
  • the longitudinal reflector 62 can be formed as a partial layer or foil element within a laminate structure, e.g., between layer 20 and layer 30.
  • the longitudinal reflector 62 illustrated in FIGS. 5 and 5A cooperates with the scatterer medium 22 to create an azimuthal exposure pattern of approximately 180°, although it should be clear that other angles of exposure can be simply achieved by widening (or narrowing) the circumferential extent of the reflector element 62.
  • the reflector can be disposed on the outside of the housing or can be formed as a coating rather than a foil element.
  • the longitudinal reflector can be used without reflective end surface 28, if enhanced axial uniformity is not needed.
  • FIG. 6A an alternative design is shown for the end reflector.
  • end reflector 28A presents a convex surface to the scattering medium and, thereby, varies the exposure pattern.
  • FIG. 6B yet another alternative design for the end reflector is shown, wherein the reflective surface is disposed at the distal rather than proximal end face of the plug 26.
  • plug 26 is optically transmissive and the reflecting surface 28B is formed as a concave surface.
  • a filler element 29 may also be disposed at the end of the tube 20.
  • FIGS. 7A-7C the effects of different scatterer concentrations on the diffusion pattern of the tip assembly is illustrated.
  • the optimal concentration of scatterer particles incorporated into the scatterer medium will, of course, vary with the diameter of the tube, the length of the tube and the wavelength as well as other factors. Nonetheless, a optimal concentration can be readily determined empirically.
  • FIG. 7 A illustrates the situation where too many scatterers have been loaded. Most of the light is diffused immediately upon entry into the scatterer tube.
  • FIG. 7B illustrates the situation where the scatterer medium is too dilute and a bright spot occurs in the vicinity of the reflector.
  • FIG.7C illustrates a preferred embodiment of the present invention in which the scatterer concentration and mirror location are chosen such that the light is diffused in a substantially uniform axial pattern.
  • FIG. 8 illustrates how the mirror placement changes the exposure pattern for a given light source, tube diameter and scatterer concentration. As the tube is extended and the distance between the fiber and mirror increases, a drop-off in uniformity is observed. Again, optimal dimensions for a particular application can be determined empirically.
  • FIG. 9 is graph of intensity for one preferred embodiment of the invention, a fiber tip assembly similar to that shown in FIG. 1 have a Teflon® FEP tubular housing (O.D. of about 0.5 millimeters and I.D. of about 0.25 millimeters) filled with a silicone and titania scatterer composition and capped with an aluminum-coated reflective rnirror.
  • the scatterer medium was formulated by mixing 70 parts of clear silicone, MastersilTM Formula 151 -Clear (available from Masterbond, Inc. of Hackensack, New Jersey) with one part of titania filled silicone, Masters..TM Formula 151-White (also available from Masterbond). The result was a diffusive tip assembly which uniformly transmitted red light at about 633 nanometers over its entire length of 25 millimeters.
  • FIG. 10 illustrated the azimuthal exposure patterns for two embodiments of the present invention.
  • the pattern formed by the squares represents intensity of light diffused outwardly with a fiber tip assembly similar to that shown in FIG. 1.
  • This azimuthal exposure pattern is essentially isotropic.
  • the pattern formed by the diamonds represents intensity of light diffused outwardly with a fiber tip assembly similar to that shown in FIG. 5.
  • This azimuthal exposure pattern is essentially semi-cylindrical.
  • An exemplary manufacturing process suitable for joining a diffuser assembly to a glass-clad or polymer-clad optical fiber having an outer diameter of about 50 to about 1000 micrometers can begin by stripping off the buffer from the end of the optical fiber, e.g., exposing about two or three millimeters of the inner fiber core and its cladding. (It is not necessary to strip the cladding away from the core.)
  • the fiber end face Prior to stripping, the fiber end face preferably should be prepared and polished as known in the art to minimize boundary or interface losses.
  • a transparent tubular structure which will form the housing for the scatterer medium is then slipped over the prepared fiber end and, preferably slid beyond the fiber end.
  • the tubing can be about 100 millimeters long and slid over about 75 millimeters of the fiber, leaving an empty lumen of about 25 millimeters in front of the fiber end face.
  • the housing is Teflon® FEP tubing, available, for example, from Zeus Industries (Raritan, New Jersey).
  • FIG. 11 illustrates the transmission spectrum of Teflon® FEP, showing that this material is well suited for use as a scatterer-encasing material across a spectrum of light from infrared to ultraviolet.
  • a scatterer-loaded material such as a silicone, epoxy or other polymeric material(if a solid diffuser is desired) or a suitable liquid, such as water or a deuterium oxide solution, containing colloidal scatterer particles, such as silica, alumina, or titania, (if a liquid diffuser is desired).
  • a scatterer medium can be formulated by mixing 70 parts of clear silicone, MastersilTM Formula 151-Clear (available from Masterbond, Inc. of Hackensack, New Jersey) with one part of titania filled silicone, MastersilTM Formula 151-White (also available from Masterbond), and a conventional silicone curing or hardening agent.
  • the tube lumen should be completely filled with the silicone, epoxy or other carrier mixture to avoid entrapment of air bubbles.
  • the reflector e.g., an aluminum, gold or other reflector-coated plug
  • the reflector at the distal end of the scatterer tube can be a deposited metal or dielectric coating.
  • a room temperature hardening agent is used and the diffuser assembly is simply allowed to solidify overnight.
  • an outer Teflon® jacket can be disposed about the apparatus to encase and protect the entire tip assembly including the inner scatterer tube and fiber end. The outer jacket is particularly useful in constructing large azimuthal angle, non- cylindrical diffusers.
  • an inner scatterer assembly is constructed and then a reflective strip is disposed along the axis of the assembly to block light diffusion where the housing is covered with the reflector and thereby define a non-cylindrical exposure pattern.
  • the extent of the circumferential coverage by the reflector will determine the azimuthal exposure pattern.
  • the use of an outer jacket also permit a wider variety of tubing choices for the inner component of the scatterer housing.
  • any transparent material can be used as the inner tube and the outer Teflon® jacket will still ensure that the problem of contact adhesion is minimized.
  • the amount of scatterer incorporated into the diffusive tip assembly will vary with the carrier and the desired length, and can therefore be adjusted to meet particular applications. Different scatterers may be more or less useful in particular applications. Table 1 below illustrates certain relevant characteristics of three different scatterer compositions:
  • composition (grams/cc) (wavelength in micrometers)
  • Liquid scatterer compositions can be used to extend phototherapy into the ultraviolet (UV) and infrared (IR) regions of the spectrum.
  • UV ultraviolet
  • IR infrared
  • structures employing deuterium oxide and other heavy water solutions are useful to transmit IR light with low losses and mmimal tip heating.
  • Distilled water suspensions of scatterers are used for UV light delivery.
  • the above-described manufacturing techniques were used to produce diffusing tips joined to fibers ranging from about 100 to about 600 micrometers in diameter. When fiber bundles are joined to the diffuser tip, the individual fibers can be even smaller, e.g., as small as 25 micrometers in diameter.
  • the cylindrical light-diffusing assemblies produced axial exposure patterns of about 2 cm to about 4 cm in length.
  • the azimuthal exposure angle was either 360° for assemblies resembling FIG. 1 or about 180° for those resembling FIG. 5.
  • Other azimuthal exposure patterns can be obtained by modifying the circumferential extent of the longitudinal reflector strip 62 of FIG. 5.
  • the solid tubes were clear Teflon® and were injected with the above-described mixture of silicone and micron-sized titania.
  • the liquid- filled tubes were similarly constructed but contained a water or D 2 O solution loaded with colloidal alumina or silica.
  • a exemplary liquid scatterer composition of colloidal alumina is available as Formulation 12733 from the Johnson Matthey Co. (Seabrook, New Hampshire). In use, it is preferably diluted with water by a factor of about 100: 1 and pH-balanced with acetic acid.
  • FIG. 12 another phototherapeutic apparatus 80 according to the invention is shown having two chambers filled with different scattering media to effect an increasing diffusion pattern.
  • Apparatus 80 includes an optical fiber 12 having a light-transmissive core 14. The end face of fiber core 14 is inserted into a housing 20 which contains a first chamber with a first scattering medium 21 with individual scatterer particles 22A.
  • the housing further includes a second chamber which can have a transparent core 23 (e.g., an FEP rod or beading) surrounded by a toroidal space filled with a second medium having scatterers 22B of a different loading density or composition.
  • an end plug 26 is disposed with a mirror reflector 28.
  • Light propagating through optical fiber core 14 is transmitted into the scatterer medium 22 A and scattered in a cylindrical pattern along the length of the assembly 10. Each time the light encounters a scatterer particles, it is deflected and, at some point, the net deflection exceeds the critical angle for internal reflection at the interface between the housing 20 and medium 21. When this happens, the light will exit. Similarly, light which passes through this first chamber is transmitted to the second chamber 23 where it encounters the scatterers 22B, causing more of the light to be reflected. Light which does not exit during this initial pass through the tip is reflected by the mirror 28 and returned through the tip assembly. During the second pass, the remaining radiation (or at least a major portion of this returning radiation) again encounters the scatterers 22 A and 22B which provide further circumferential diffusion of the light.
  • FIG. 13 another phototherapeutic apparatus 100 is shown including a jacket 112 having a plurality of light diffusing loops 114 A, 114B which can be expanded out of, or retracted back into, the instrument housing 112 by control wire 116. As shown, the apparatus 100 can further include a radio opaque region 118 which facilitates location of the instrument by radiographic means. Although the apparatus is illustrated with only two loops, in some applications it can be desirable to have a greater (or lesser) number of loops.
  • FIGS. 14A-14D the deployment of loop elements 114A and 114B is shown schematically.
  • FIG. 14A illustrates a fully retracted mode in which most of the loop elements are withdrawn into the housing 112.
  • a control wire 116 has been moved partially forward and a larger portion of diffusive loop elements 114A and 114B projects outward from the housing 112.
  • FIG. 14C the control wire has been slid forward even further and the loop elements 114A, 114B now are nearly fully deployed.
  • FIG. 14D the control wire 116 is partially retracted after extension to effect a "heart-shaped" diffuser.
  • FIG. 14A illustrates a fully retracted mode in which most of the loop elements are withdrawn into the housing 112.
  • FIG. 14B a control wire 116 has been moved partially forward and a larger portion of diffusive loop elements 114A and 114B projects outward from the housing 112.
  • FIG. 14C the control wire has been slid forward even further and the loop elements 114
  • ISA a truncated, cross-sectional view of a diffusive loop element 114 is shown connected to two optical fibers, each having a light transmissive core 120A, 120B and a cladding/buffer coating 129.
  • the end face of each fiber core 120A, 120B is inserted into a housing 128 which contains a scattering medium 124 with optional individual scatterer particles 125.
  • the medium 124 has a greater refractive index than the housing 128.
  • FIG. 15B is a graph of intensity vs. radial distance for two fibers as shown in FIG. 15A.
  • the curve 121 A illustrates the intensity of diffused radiation vs. axial length of one fiber while curve 121B represents a similar intensity distribution for a second fiber which has been deployed in an opposite configuration.
  • the cumulative intensity distribution of these two fibers are shown by curve 123.
  • FIG. 16 A similar radiation distribution pattern can be achieved by employing a reflective end cap on each loop, as shown in FIG. 16.
  • a truncated, cross-sectional view of a diffusive loop element 114 is shown having an optical fiber with a light transmissive core 120 and a cladding/buffer coating 129.
  • the end face of fiber core 120 is inserted into a housing 128 which contains a scattering medium 124 with optional individual scatterer particles 125.
  • the medium 124 has a greater refractive index than the housing 128.
  • an end plug 126 is disposed at the distal end of the housing 128.
  • the end plug may also be fitted with a mirror reflector 140 to create a distribution pattern like that shown in FIG. 15B.
  • the housing can either be made sufficiently long to ensure that virtually all of the light entering it is eventually scattered and diffused in a single path, or as noted above, a reflective mirror can be fitted to the distal end of each diffuser assembly. When a mirror is employed, light propagating through the medium 124 will be at least partially scattered before it reaches mirror 140.
  • the loop diffuser apparatus of the present invention 10 is shown schematically in operation.
  • the diffuser apparatus 100 is coupled to a source of phototherapeutic radiation 136 (e.g., a laser) and positioned within a patient's body to provide phototherapy.
  • a source of phototherapeutic radiation 136 e.g., a laser
  • the diffuser assembly can be designed to fit within the instrument channel of an endoscope 132.
  • the endoscope can further include viewing means 134 and/or at least one additional channel 138 for the introduction of irrigation saline or therapeutic solutions.
  • the diffusing assemblies of the present invention can be incorporated into catheter-type instruments that are introduced into the patient's body without the assistance of an endoscopic channel.
  • an outer jacket (e.g., of Teflon® material) is shown disposed about the apparatus to encase the fiber 112 and loop diffuser assembly 114.
  • the outer sheath surrounds the entire optical transmission apparatus and ensures that the radiation-generating components do not come into direct contact with the patient's body and, thereby, permits reuse of the instrument. Only the outer sheath 150 needs to be disposed after each use.
  • the devices of the present invention can be used for various therapeutic purposes.
  • One application is photodynamic therapy (PDT), a form of light-activated chemotherapy.
  • PDT photodynamic therapy
  • photosensitive dyes are delivered by injection or other vehicles such that the dye is preferentially accumulated in cancer cells.
  • an appropriate wavelength e.g., with red light
  • a photochemical reaction occurs that yields radicals (usually singlet oxygen) which poison the cell.
  • the present invention further encompasses the use of diffused radiation to activate photosensitive dyes.
  • the present invention permits PDT at remote treatment sites via a catheter, trocar, hollow needle or other hand held instrument in a minimally invasive manner because diffusive fiber tip assemblies can now be constructed with outer diameters on the order of only a few hundred micrometers.
  • the present invention also encompasses the use of diffuse radiation in photocoagulation and/or hypodermic therapy of tumors and hyperplasia.
  • the phototherapy apparatuses described above can be used to treat liver, pancreatic or prostate tumors, or benign prostate hyperplasia.
  • the application of diffuse radiation to heat prostate tissue can be used in lieu of transurethral resection of the prostate, balloon dilatation of the prostate or ultrasonic hyperthermia.
  • the directional probes described above can be especially useful in improving the outcome of prostate treatment by heating more tissue directly in less time, and in distributing irradiation over a larger volume of prostatic tissue, thus increasing the therapeutic heating effects while reducing the risk of overheating damage to surrounding tissue structures such as the sphincter.
  • the invention further permits interstitial laser coagulation of hepatic and pancreatic tumors.
  • the desired effects are achieved by thermal destruction of cancerous tissue by depositing laser radiation via a diffusive fiber tip carrier by a hypodermic needle or similar instrument inserted percutaneously into the tumor. In each of these procedures, therapy can be delivered while the patient is awake; general anesthesia as well as open surgery are avoided.
  • the diffusive fiber tip assemblies of the present invention allow for the formation of large distributed heat sources within the target tissue.
  • the invention significantly alters the rate of heat deposition in tissue, especially in the regions immediately surrounding the fiber tip, where tissue overheating and/or carbonization would limit the effectiveness and inhibit efficient heat transfer. Since the radiation is distributed by the diffuser assembly over a larger volume of tissue, more tissue is heated directly and there is less need to rely on convective or conductive heat transfer through nearby tissue to reach the periphery of the tumor.
  • the materials disclosed herein for the diffusive tips and jackets further enhance the therapeutic effects by permitting high radiation transmission and low absorption, thereby ensuring the tip assembly itself does not overheat during usage.
  • the use of Teflon® tubes and/or coatings further improve the procedures by avoiding the problem of tip fusion or contact-adhesion between the tip assembly and biological tissue during usage.
  • Teflon® FEP materials polyperfluoroethylene-propylene copolymers
  • Teflon® PF A materials polytetrafluoroethylene polymers with perfluoroalkoxy side chains
  • Teflon® PTFE polytetrafluoroethylene
  • the non-cylindrical, large azimuthal angle diffusers of the present invention are also particularly useful in therapeutic applications.
  • the devices disclosed herein can provide therapeutic radiation to large volumes of tissue while also protecting sensitive tissue or biological structures.
  • a semi-cylindrical or other large azimuthal angle diffuser can disposed within the urethra and rotated into a position such that the prostate is subjected to phototherapy while the patient's sphincter muscles and or other tissue regions are largely shielded from irradiation.
  • the non-cylindrical diffusive tip assemblies can be used to deliver a greater dose of radiation to tissue and rotated, if necessary during use to effect a circumferential (or partially- circumferential scan of the target tissue at the higher intensity level.
  • the diffusive tip assemblies of the present invention can be used in various other medical applications, such as, for example, heat-setting of stents, activation of photoreactive suturing materials, curing of prosthetic devices, activation of adhesives for implants and the like.
  • FIG. 19 yet another phototherapeutic apparatus 200 according to the invention is illustrated having a tubular sheath 212 and an inner optically-transmissive fiber element 214.
  • the distal end of the sheath 212 is fluted such that axial compression of the sheath results in expansion of strut elements 218 in the fluted region 216.
  • Fig 20 is a more detailed cross-sectional view of the distal end of the apparatus of Fig. 19.
  • the optically-transmissive element is shown having an optical fiber 220 with an optically transmissive core 222 surrounded by a cladding, and buffer coating.
  • the end face of fiber core 222 is inserted into a housing 228 which contains a scattering medium 224 with optional individual scatterer particles 225.
  • the medium 224 has a greater refractive index than the housing 228.
  • the end cap 226 can be disposed at the distal end of the housing 228, and end cap 226 can be disposed.
  • the end cap may also be fitted with a reflective mirror 240.
  • the end cap 226 can further be ground or polished to a point 230 to facilitate penetration of body tissue.
  • Light propagating through the optical fiber core 222 is transmitted into the scatterer medium and scattered in an cylindrical pattern along the length of the assembly 214. Again, each time the light encounters a scatterer particle, it is deflected and, at some point, the net deflection exceeds the critical angle for internal reflection at the interface between the housing 228 and the medium 224. When this happens the light will exit.
  • the housing can either be made sufficiently long to ensure that virtually all of the light entering it is eventually scattered and diffused in a single path, or as noted above, a reflective mirror can be fitted to the distal end of each diffuser assembly. When a mirror is employed, light propagating through the medium 224 will be at least partially scattered before it reaches mirror 240.
  • the phototherapeutic apparatus in the present invention 200 is shown schematically in operation.
  • the diffuser apparatus with its fluted stopper is coupled to a source of phototherapeutic radiation 236, (e.g., a laser) and positioned within a patient's body to provide phototherapy.
  • a source of phototherapeutic radiation 236, e.g., a laser
  • the diffuser assembly can be designed to fit within a standard guiding catheter 232.
  • the catheter 232 can further include electrical sensing elements 234 and/or at least one additional channel 238 for introduction of saline or therapeutic solutions.
  • the use of the phototherapeutic apparatus of the present invention is shown schematically.
  • the instrument 200 is positioned next to a segment of a patient's body tissue where penetration and radiation is desired.
  • the apparatus includes an outer sheath 212 having a fluted region 216 and an inner optically-transmissive fiber element 214 with tip 226.
  • the fiber 214 and sheath 212 are constructed with sufficient clearance to permit saline or other therapeutic liquids to be released during the procedure.
  • saline flushing of the fiber tip 214 may be desirable to cool the tissue surface proximal to the treatment site.
  • Fig. 22B initial penetration of the apparatus 200 is shown.
  • the optically-transmissive fiber has penetrated the patient's tissue but the end 217 of sheath 212 has not yet touched the tissue surface.
  • Fig. 22C the fiber 214 has penetrated further into the patient's tissue and the sheath 212 has now been pushed into a position abutting the patient's tissue.
  • the fluted region 216 begins to expand due to the compressive forces exerted during penetration.
  • Struts 218 are pushed out radially from the body of the apparatus.
  • the apparatus is shown in a fully deployed position wherein a predetermined length of the optical fiber 214 has now penetrated the patient's body tissue and the radially-expanded struts 218 have been fully compressed into a maximal position creating a large cross-sectional obstruction to further penetration.
  • Various materials can be used to form the outer sheath including, for example,
  • the struts 218 can be formed by axial slices at various locations on the sheath. For example to construct a four strut stopper device, one would make four longitudinal cuts into the sheath, separated by 90° from each other. The length of the cuts will determine the radial extent of the stopper. In one embodiment it may also be desirable to fill the sheath polymer with a radio-opaque substance, such as barium or bismuth in order to permit visualization under angiography.
  • a radio-opaque substance such as barium or bismuth
  • FIG. 23 a further adaptation of the present invention is shown in a phototherapeutic apparatus 300 for sterilizing an inner lumen of an endoscopic medical instrument 332 is shown including a source of ultraviolet radiation 336, an optical fiber 312 and a diffusive tip assembly 314.
  • the apparatus 300 serves to sterilize or clean an inner lumen of the endoscopic instrument 332.
  • the optical fiber 312 with its light-diffusing distal tip assembly 314 is inserted into the lumen requiring sterilization.
  • the optical fiber tip can be inserted through the entire instrument and then slowly retracted.
  • the radiation source is activated to transmit light via the fiber 312 to the diffusive tip assembly 314.
  • cytotoxic radiation is delivered to all portions of the inner lumen walls. Any debris or deposits on the inner lumen walls are likewise irradiated to kill any microbes which may be harbored in such deposits.
  • a diffusive tip assembly 314 is shown in more detail proving the optical fiber 312 having a light transmissive core 320 and a buffer coating or cladding 321.
  • the end face of fiber core 320 is inserted into a housing 328 which contains a scattering medium 324 with optional individual scattering particles 325.
  • the medium 324 again has a greater refractive index than the housing 328.
  • an end plug 326 is disposed with a mirror reflector 340.
  • Light propagating through the optical fiber core 320 is transmitted into the scatterer medium 324 and scattered in a cylindrical pattern along the length of the assembly 314. Each time the light encounters a scatterer particle, it is deflected and, at some point, the net deflection exceeds the critical angle for internal reflectance at the interface between the housing 328 and the medium 324. When this happens, the light will exit. Light which does not exit during the initial pass through the tip is reflected by the mirror 328 and returned through the tip assembly. During the second pass, the remaining radiation (or at least the major portion of this returning radiation) again encounters the scatterers 325 which provide further circumferential diffusion of the ultraviolet light.
  • the optimal concentration of scatterer particles incorporated into this scatterer medium will, of course, vary with the diameter of the tube, the length of the tube and the wavelength as well as other factors. Nonetheless, an optimal concentration can readily be determined empirically for ultraviolet radiation in the range of about 400 nanometers to about 200 nanometers, one preferred composition for the scatterer medium is colloidal alumina suspended in acetic acid. It should also be appreciated that the length of the scatterer tube (e.g., the distance between the fiber end facing and the reflector) will also affect the uniformity of the diffused radiation.
  • an outer Teflon® jacket 350 can be disposed about the apparatus as a final step to encase and protect the entire tip assembly including the inner scatterer tube 314 and fiber end 312.
  • the apparatus is slid into an endoscope lumen and connected to a UV light source.
  • the light source is activated and the UV radiation is transmitted to the diffusive tip, where the scatterers project a cylindrical exposure pattern to the lumen walls.
  • the apparatus can then be slid forward or backwards (or in both directions) to bathe the entire lumen with sterilizing irradiation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Radiation-Therapy Devices (AREA)
  • Laser Surgery Devices (AREA)
  • Polarising Elements (AREA)
  • Surgical Instruments (AREA)
  • Harvester Elements (AREA)

Abstract

L'invention concerne des ensembles-embouts de fibres, à transmission optique, dans lesquels sont incorporées des particules diffusant un rayonnement, utilisés en photothérapie. Selon une variante, l'invention concerne des diffuseurs pourvus de capuchons terminaux réfléchissants. Lorsqu'un rayonnement se propage à travers l'embout de fibre, une partie des rayons est diffusée selon une configuration cylindrique (ou partiellement cylindrique) le long de l'embout de fibre. Le rayonnement qui n'est pas diffusé pendant ce passage initial à travers l'embout peut être réfléchi par au moins une seule face de l'ensemble embout et renvoyé à travers l'embout. Pendant ce second passage, le rayonnement résiduel (ou au moins une partie importante de ce rayonnement réfléchi) rencontre de nouveau les diffuseurs qui créent une autre diffusion radiale de ce rayonnement. Le milieu de diffusion et le capuchon terminal réfléchissant peuvent interagir pour produire une répartition axiale (ou autrement prédéfinie), pratiquement uniforme, du rayonnement laser sur la longueur de l'embout qui forme l'appareil présenté. Selon une autre variante, l'invention concerne des ensembles-boucles de diffusion qui servent à diffuser une rayonnement provenant d'une fibre optique. L'invention concerne également des gaines jetables ainsi que des dispositifs d'arrêt solidaires de l'embout qui limitent la pénétration de l'appareil. Les appareils selon l'invention peuvent être utilisés à différentes fins d'ordre médical ainsi que pour stériliser des instruments médicaux.
EP95933733A 1994-09-09 1995-09-08 Appareil de phototherapie Ceased EP0781154A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05000735A EP1527798A3 (fr) 1994-09-09 1995-09-08 Ensemble embout diffuseur.

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US30360594A 1994-09-09 1994-09-09
US303605 1994-09-09
US467414 1995-06-06
US08/471,744 US5637877A (en) 1995-06-06 1995-06-06 Ultraviolet sterilization of instrument lumens
US468568 1995-06-06
US08/467,414 US5632767A (en) 1994-09-09 1995-06-06 Loop diffusers for diffusion of optical radiation
US08/468,568 US5643253A (en) 1995-06-06 1995-06-06 Phototherapy apparatus with integral stopper device
US471744 1995-06-06
PCT/US1995/011246 WO1996007451A2 (fr) 1994-09-09 1995-09-08 Appareil de phototherapie

Publications (1)

Publication Number Publication Date
EP0781154A2 true EP0781154A2 (fr) 1997-07-02

Family

ID=27501834

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95933733A Ceased EP0781154A2 (fr) 1994-09-09 1995-09-08 Appareil de phototherapie

Country Status (7)

Country Link
EP (1) EP0781154A2 (fr)
JP (1) JP3675482B2 (fr)
KR (1) KR970706039A (fr)
CN (1) CN1072971C (fr)
AU (1) AU725320B2 (fr)
CA (1) CA2199384C (fr)
WO (1) WO1996007451A2 (fr)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579285B2 (en) 1994-09-09 2003-06-17 Cardiofocus, Inc. Photoablation with infrared radiation
US6558375B1 (en) 2000-07-14 2003-05-06 Cardiofocus, Inc. Cardiac ablation instrument
US6102905A (en) * 1994-09-09 2000-08-15 Cardiofocus, Inc. Phototherapy device including housing for an optical element and method of making
US6270492B1 (en) 1994-09-09 2001-08-07 Cardiofocus, Inc. Phototherapeutic apparatus with diffusive tip assembly
US6676656B2 (en) 1994-09-09 2004-01-13 Cardiofocus, Inc. Surgical ablation with radiant energy
US8025661B2 (en) * 1994-09-09 2011-09-27 Cardiofocus, Inc. Coaxial catheter instruments for ablation with radiant energy
US5947959A (en) * 1994-09-09 1999-09-07 Rare Earth Medical, Inc. Phototherapeutic apparatus with diffusive tip assembly
AU718841B2 (en) * 1995-10-31 2000-04-20 Indigo Medical, Incorporated Light-diffusing device for an optical fiber, methods of producing and using same, and apparatus for diffusing light from an optical fiber
US5773835A (en) * 1996-06-07 1998-06-30 Rare Earth Medical, Inc. Fiber optic spectroscopy
DE69738826D1 (fr) * 1996-11-21 2008-08-21 Boston Scient Ltd
US6200307B1 (en) 1997-05-22 2001-03-13 Illumenex Corporation Treatment of in-stent restenosis using cytotoxic radiation
FR2767704A1 (fr) * 1997-09-04 1999-02-26 Medlight Sa Dispositif diffuseur de lumiere pour le traitement photodynamique d'organes
US6096030A (en) * 1997-09-23 2000-08-01 Pharmacyclics, Inc. Light delivery catheter and PDT treatment method
US6071302A (en) * 1997-12-31 2000-06-06 Cardiofocus, Inc. Phototherapeutic apparatus for wide-angle diffusion
US6289229B1 (en) 1998-01-20 2001-09-11 Scimed Life Systems, Inc. Readable probe array for in vivo use
US6464625B2 (en) * 1999-06-23 2002-10-15 Robert A. Ganz Therapeutic method and apparatus for debilitating or killing microorganisms within the body
US8900219B2 (en) 1999-07-14 2014-12-02 Cardiofocus, Inc. System and method for visualizing tissue during ablation procedures
US8540704B2 (en) 1999-07-14 2013-09-24 Cardiofocus, Inc. Guided cardiac ablation catheters
US9033961B2 (en) 1999-07-14 2015-05-19 Cardiofocus, Inc. Cardiac ablation catheters for forming overlapping lesions
AU6616700A (en) 1999-07-30 2001-02-19 Cardiofocus, Inc. Laser method and apparatus for treatment of tissue
DE20003349U1 (de) * 2000-02-24 2000-06-08 Laser & Med Tech Gmbh Vorrichtung für die thermische Behandlung von biologischem Gewebe
US6551346B2 (en) * 2000-05-17 2003-04-22 Kent Crossley Method and apparatus to prevent infections
HU224941B1 (en) 2001-08-10 2006-04-28 Bgi Innovacios Kft Phototerapy apparatus
CA2475111A1 (fr) 2002-02-05 2003-08-14 Pharmacyclics, Inc. Dispositif de transmission de lumiere faisant intervenir un systeme de diffusion conique et son procede de fabrication
JP2005534409A (ja) * 2002-08-05 2005-11-17 ミラヴァント メディカル テクノロジーズ，インコーポレーテッド 光伝達カテーテル
AU2003258124A1 (en) * 2002-08-05 2004-02-23 Miravant Medical Technologies Light delivery catheter
US20050273090A1 (en) * 2004-06-07 2005-12-08 Tim Nieman Methods and devices for directionally ablating tissue
US8109981B2 (en) 2005-01-25 2012-02-07 Valam Corporation Optical therapies and devices
DE102006016957B4 (de) * 2006-04-11 2010-04-22 Vimecon Gmbh Laserapplikator
WO2008066206A1 (fr) * 2006-11-30 2008-06-05 Keio University Appareil de blocage d'une conduction électrique anormale par thérapie photodynamique (tpd)
EP2365843A1 (fr) * 2008-11-03 2011-09-21 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Dispositif d'irradiation d'une surface interne du corps
JP5598935B2 (ja) * 2010-02-26 2014-10-01 学校法人慶應義塾 光化学反応により心筋組織の光線力学的アブレーションを行うカテーテル
JP5486422B2 (ja) * 2010-06-28 2014-05-07 株式会社日本ゲルマニウム研究所 健康器具
ES2607613T3 (es) * 2011-03-11 2017-04-03 Steba Maor Sa Métodos de planificación de terapia fotodinámica focal
CN104415464A (zh) * 2013-08-19 2015-03-18 李永皓 皮肤病治疗装置、激光在治疗皮肤病中的用途和消毒方法
JP2015097664A (ja) * 2013-11-19 2015-05-28 株式会社アライ・メッドフォトン研究所 医療用具及び光線治療装置
WO2015080868A1 (fr) 2013-11-26 2015-06-04 Corning Incorporated Système et procédé de distribution de lumière antibactérienne pour désinfecter une surface
EP3137007A4 (fr) 2014-04-28 2017-09-27 Cardiofocus, Inc. Système et procédé pour visualiser un tissu avec une composition de colorant icg pendant des procédures d'ablation
US10307495B2 (en) * 2014-09-19 2019-06-04 Sharp Kabushiki Kaisha Sterilizing apparatus
WO2016089900A2 (fr) 2014-12-03 2016-06-09 Cardiofocus, Inc. Système et procédé de confirmation visuelle d'isolement des veines pulmonaires au cours de procédures d'ablation
KR101661860B1 (ko) * 2015-09-24 2016-10-07 동성제약주식회사 치료용 의료기기 제조 방법
EP3399934B1 (fr) 2016-01-05 2022-10-12 Cardiofocus, Inc. Système d'ablation avec élément automatisé d'énergie d'ablation par balayage
BR122020013058B1 (pt) * 2016-10-25 2021-12-07 Rakuten Medical, Inc. Dispositivo de difusão de luz frontal
JP6498654B2 (ja) * 2016-11-17 2019-04-10 一般財団法人バイオダイナミックス研究所 内視鏡による光照射治療用光照射プローブ
KR20180061036A (ko) * 2016-11-29 2018-06-07 서울바이오시스 주식회사 의료용 액상 밴드 경화 장치 및 이를 이용한 액상 밴드 경화 방법
USD851245S1 (en) 2017-04-14 2019-06-11 Cardiofocus, Inc. Compliant balloon
MX2019015285A (es) * 2017-07-07 2020-02-13 Rakuten Medical Inc Dispositivos difusores de luz para su uso en fotoinmunoterapia.
DE102017122756A1 (de) * 2017-09-29 2019-04-04 Schott Ag Beleuchtungssystem mit einem Lichtleiter mit Diffusor-Element
JP7384798B2 (ja) 2018-01-15 2023-11-21 カーディオフォーカス，インコーポレーテッド 自動式アブレーションエネルギー要素を用いるアブレーションシステム
JP7091453B2 (ja) * 2018-06-11 2022-06-27 オリンパス株式会社 内視鏡用光接続モジュール、内視鏡、および、内視鏡システム
CN114587577B (zh) * 2018-06-19 2024-08-02 华科精准（北京）医疗科技有限公司 用于激光消融的装置
WO2020121887A1 (fr) * 2018-12-12 2020-06-18 株式会社フジクラ Sonde à fibre optique
JP7053547B2 (ja) * 2019-10-02 2022-04-12 タツタ電線株式会社 医療用ライトガイド及びその製造方法
CN110893242B (zh) * 2019-11-29 2021-02-02 西安交通大学 一种体内置入式导管的原位紫外线杀菌系统
CN111110346B (zh) * 2019-12-31 2021-03-09 华科精准（北京）医疗科技有限公司 用于激光间质热疗系统的装置
US11116858B1 (en) 2020-05-01 2021-09-14 Uv Innovators, Llc Ultraviolet (UV) light emission device employing visible light for target distance guidance, and related methods of use, particularly suited for decontamination
CN112915399A (zh) * 2021-03-29 2021-06-08 中国人民解放军空军军医大学 一种光纤聚能装置
CN112915400A (zh) * 2021-03-29 2021-06-08 中国人民解放军空军军医大学 一种光纤聚能装置
US11660359B2 (en) * 2021-04-19 2023-05-30 Varex Imaging Corporation Systems and methods for irradiation
WO2022224792A1 (fr) * 2021-04-23 2022-10-27 ニプロ株式会社 Cathéter d'ablation
US20220347456A1 (en) * 2021-04-30 2022-11-03 Bard Access Systems, Inc. Fiber Optic Disinfection Device
JPWO2023026930A1 (fr) 2021-08-27 2023-03-02
JPWO2023026988A1 (fr) 2021-08-27 2023-03-02
CN114569749A (zh) * 2022-03-01 2022-06-03 广东国志激光技术有限公司 一种医用介入式导管的激光消毒杀菌装置
CN115185020A (zh) * 2022-08-04 2022-10-14 江西麦帝施科技有限公司 一种扩散介质及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0292621B1 (fr) * 1987-05-26 1994-12-14 Surgical Laser Technologies, Inc. Embout laser de contact ou d'insertion à angle large de radiation
US4878492A (en) * 1987-10-08 1989-11-07 C. R. Bard, Inc. Laser balloon catheter
JP2882814B2 (ja) * 1989-08-24 1999-04-12 株式会社エス・エル・ティ・ジャパン レーザ光の照射装置
DK0437181T3 (da) * 1990-01-09 1995-03-20 Ciba Geigy Ag Apparatur til bestråling af en patients bronkier for en fotodynamisk terapi
ES2057512T3 (es) * 1990-01-09 1994-10-16 Ciba Geigy Ag Difusor de luz para una terapia fotodinamica de tumores localizados en el esofago de un paciente.
US5337381A (en) * 1993-01-21 1994-08-09 Fiberguide Industries Fiber optic cylindrical diffuser

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9607451A2 *

Also Published As

Publication number Publication date
WO1996007451A3 (fr) 1996-05-23
WO1996007451A2 (fr) 1996-03-14
CA2199384C (fr) 2006-06-06
AU725320B2 (en) 2000-10-12
KR970706039A (ko) 1997-11-03
CN1165485A (zh) 1997-11-19
CA2199384A1 (fr) 1996-03-14
CN1072971C (zh) 2001-10-17
JPH10504989A (ja) 1998-05-19
JP3675482B2 (ja) 2005-07-27
AU3626995A (en) 1996-03-27

Similar Documents

Publication Publication Date Title
CA2199384C (fr) Appareil de phototherapie
US5632767A (en) Loop diffusers for diffusion of optical radiation
US5908415A (en) Phototherapy methods and apparatus
US6270492B1 (en) Phototherapeutic apparatus with diffusive tip assembly
US5643253A (en) Phototherapy apparatus with integral stopper device
US5997571A (en) Non-occluding phototherapy probe stabilizers
US5947959A (en) Phototherapeutic apparatus with diffusive tip assembly
US6579285B2 (en) Photoablation with infrared radiation
EP1200002B1 (fr) Systeme de photoablation
CA2255714C (fr) Dispositifs et procedes phototherapeutiques ameliores servant a eclairer des voies corporelles
EP1309285B1 (fr) Diffuseur de lumiere pour therapie photodynamique
US20040167503A1 (en) Malleable surgical ablation instruments
US20050165462A1 (en) Light delivery device using conical diffusing system and method of forming same
AU2001290540A1 (en) Photodynamic therapy light diffuser
JP2007528754A (ja) 光ダイナミック療法をするために内腔内に自動調心する光発生装置
EP1527798A2 (fr) Ensemble embout diffuseur.
AU5195700A (en) Phototherapeutic apparatus
US9168098B2 (en) Light-based method for the endovascular treatment of pathologically altered blood vessels

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970408

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): CH DE DK ES FR GB IE IT LI NL SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CARDIOFOCUS, INC.

17Q First examination report despatched

Effective date: 20020405

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

APAA Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOS REFN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20041215

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE